España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Pacira BioSciences
PCRX
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
Get Report
Comment
Pacira BioSciences (PCRX) Forecast
News
Earnings
Pacira BioSciences (PCRX) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Government Trades
Short Interest
Latest news for Pacira BioSciences (NASDAQ:PCRX) Stock
Pacira BioSciences Stock (NASDAQ: PCRX)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, December 04, 2024
Decoding 6 Analyst Evaluations For Pacira BioSciences
Benzinga Insights
HC Wainwright & Co. Reiterates Buy on Pacira ...
Benzinga Newsdesk
Tuesday, December 03, 2024
Pacira Biosciences Received U.S. Patent No. 1...
Benzinga Newsdesk
Pacira Secures New U.S. Patent For EXPAREL Co...
Benzinga Newsdesk
Thursday, November 14, 2024
Pacira Reports 104-Week Safety And Efficacy D...
Benzinga Newsdesk
Tuesday, November 12, 2024
Barclays Maintains Equal-Weight on Pacira Bio...
Benzinga Newsdesk
Friday, November 08, 2024
Needham Reiterates Buy on Pacira BioSciences,...
Benzinga Newsdesk
Thursday, November 07, 2024
Evaluating Pacira BioSciences: Insights From 8 Financial Analysts
Benzinga Insights
RBC Capital Maintains Sector Perform on Pacir...
Benzinga Newsdesk
Wednesday, November 06, 2024
Pacira BioSciences Sees FY24 Revenue $680M-$7...
Benzinga Newsdesk
Pacira BioSciences Q3 2024 Adj. EPS $0.83 Bea...
Benzinga Newsdesk
Tuesday, November 05, 2024
Insights into Pacira BioSciences's Upcoming Earnings
Benzinga Insights
Monday, October 21, 2024
Pacira BioSciences Appoints Shawn Cross As Ch...
Benzinga Newsdesk
Friday, October 04, 2024
RBC Capital Maintains Sector Perform on Pacir...
Benzinga Newsdesk
Thursday, October 03, 2024
Pacira BioSciences Announces New Product-Spec...
Benzinga Newsdesk
Thursday, September 26, 2024
Pacira To Present 104-Week Safety And Efficac...
Benzinga Newsdesk
Wednesday, September 25, 2024
DOMA Perpetual Sends Letter To Board of Direc...
Benzinga Newsdesk
Tuesday, September 24, 2024
Expert Ratings For Pacira BioSciences
Benzinga Insights
Jefferies Maintains Buy on Pacira BioSciences...
Benzinga Newsdesk
Tuesday, August 13, 2024
Truist Securities Downgrades Pacira BioScienc...
Benzinga Newsdesk
Monday, August 12, 2024
Pain Management-Focused Pacira BioSciences Loses Patent Fight For Key Drug, JP Morgan Analyst Downgrades On Unclear Path
Vandana Singh
Where Pacira BioSciences Stands With Analysts
Benzinga Insights
RBC Capital Downgrades Pacira BioSciences to ...
Benzinga Newsdesk
JetBlue Airways, B. Riley Financial, Hawaiian Electric And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Avi Kapoor
HC Wainwright & Co. Maintains Buy on Pacira B...
Benzinga Newsdesk
Needham Maintains Buy on Pacira BioSciences, ...
Benzinga Newsdesk
JP Morgan Downgrades Pacira BioSciences to Un...
Benzinga Newsdesk
Friday, August 09, 2024
Pacira BioSciences Shares Resume Trading, The...
Benzinga Newsdesk
Pacira BioSciences Shares Halted On Circuit B...
Benzinga Newsdesk
Pacira BioSciences Shares Resume Trade
Benzinga Newsdesk
Pacira BioSciences shares are trading lower a...
Benzinga Newsdesk
Pacira BioSciences Announces The U.S. Distric...
Benzinga Newsdesk
Pacira BioSciences Shares Halted On Circuit B...
Benzinga Newsdesk
Wednesday, July 31, 2024
Raymond James Maintains Outperform on Pacira ...
Benzinga Newsdesk
RBC Capital Maintains Outperform on Pacira Bi...
Benzinga Newsdesk
Pacira BioSciences shares are trading higher ...
Benzinga Newsdesk
Needham Reiterates Buy on Pacira BioSciences,...
Benzinga Newsdesk
Tuesday, July 30, 2024
Pacira BioSciences shares are trading higher ...
Benzinga Newsdesk
Pacira BioSciences Reiterates Full-year 2024 ...
Benzinga Newsdesk
Pacira BioSciences Q2 2024 Adj. EPS $0.89 Bea...
Benzinga Newsdesk
Thursday, July 25, 2024
Expert Ratings For Pacira BioSciences
Benzinga Insights
Truist Securities Maintains Buy on Pacira Bio...
Benzinga Newsdesk
Wednesday, July 10, 2024
Pacira BioSciences Announces Centers For Medi...
Benzinga Newsdesk
Monday, July 08, 2024
This Is What Whales Are Betting On Pacira BioSciences
Benzinga Insights
Top 5 Health Care Stocks That May Explode In July
Avi Kapoor
Wednesday, July 03, 2024
This Charter Communications Analyst Turns Bearish; Here Are Top 5 Downgrades For Wednesday
Avi Kapoor
Piper Sandler Maintains Overweight on Pacira ...
Benzinga Newsdesk
Barclays Downgrades Pacira BioSciences to Equ...
Benzinga Newsdesk
Tuesday, July 02, 2024
Pacira BioSciences shares are trading lower a...
Benzinga Newsdesk
U.S. FDA Approves Generic Version Of Exparel,...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch